From neuroscience to neurology
Subtitle: neuroscience, molecular medicine, and the therapeutic transformation of neurology
By: edited by Stephen Waxman.
Contributors: Waxman, Stephen G.
Publisher: Elsevier Academic Press
Published: 2005
Place of publication: Amsterdam; Boston
Language: eng
Number of pages: 513
Subjects: Neurosciences -- History -- Popular works.; Neurology -- History -- Popular works.; Nervous System Diseases -- therapy.
Genres: Popular works.
Description: This book, which contains chapters by more than 29 internationally recognized authorities who have made major contributions to neurotherapeutics, tells the stories of how new treatments for disabling disorders of the nervous system, such as stroke, multiple sclerosis, Parkinson's disease, and migraine, were developed, and explores evolving themes and technologies that offer hope for even more effective treatments and ultimately cures for currently untreatable disorders of the brain and spinal cord.
Notes: Includes bibliographical references and index.
Table of contents: title: Seeing the brain so we can save it: the evolution of magnetic resonance; title: Imaging as a clinical tool; title: Advances in the acute treatment and secondary prevention of stroke; title: Preserving function in acute nervous system injury; title: Slowing the progression of multiple sclerosis; title: The emergence of neurosurgical approaches to the treatment of epilepsy; title: The neurobiology of migraine and transformation of headache therapy; title: Botulinum toxins: transformation of a toxin into a treatment; title: Prospects for slowing the progression of Parkinson's disease; title: Current neurosurgical treatments for Parkinson's disease: where did they come from?; title: Treatable peripheral neuropathies: plasma exchange, intravenous immunoglobulin, and other emerging therapies; title: Molecular pharmacology and the treatment of Tourette's syndrome and attention deficit-hyperactivity disorder; title: Neuroscience, molecular medicine, and new approaches to the treatment of depression and anxiety; title: Genomics, proteomics, and neurology; title: Neuroprotection: where are we going?; title: Prospects for gene therapy for central nervous system disease; title: Therapeutics development for hereditary neurological diseases; title: Inherited channelopathies of the CNS: lessons for clinical neurology; title: Inherited channelopathies of muscle: implications for therapy; title: Transcriptional channelopathies of the nervous system: new targets for molecular medicine; title: New molecular targets for the treatment of neuropathic pain; title: Therapeutic transfer and regeneration of neural progenitors or neurons in gray matter of the adult brain; title: Cellular plasticity of the adult human brain; title: Harnessing endogenous stem cells for central nervous system repair; title: Neuropathies-translating causes into treatments; title: Inherited neuropathies; title: Therapeutic potential of neurotrophic factors; title: Promoting the regeneration of axons within the central nervous system; title: Alzheimer's disease: clinical features, neuropathological and biochemical abnormalities, genetics, models, and experimental therapeutics; title: Behavioral intervention and recovery from CNS damage; title: What functional brain imaging will mean for neurology.